Table 1

Univariate Analysis of Disease Free Survival – 368 Eligible Patients. In grey: Follow up (2011)

Variable

No. of patients

P value


Age

Mean = 58.7 yr

0.400

Menopauses

Yes

237 (65%)

No

124 (34%)

Localization

Right breast

176 (47.8%)

Left breast

187 (50.8%)

Synchronous bilateral

5 (01.4%)

Tumor size

Mean = 25 mm

0.010

Surgery

Tumorectomy

212 (57.6%)

Mastectomy

141 (38.3%)

Biopsy

15 (04.1%)

Excision quality

Satisfying

202 (57.2%)

Unsatisfying

47 (13.3%)

Unspecified

104 (29.5%)

Histological type

ICC

297 (80.71%)

ILC

37 (10.05%)

SBR grade

Grade 1

50 (14%)

Grade 2

180 (49%)

0.002

Grade 3

137 (37%)

Mitotic index (/1.7mm²)

Mean = 10 mitosis

<0.0001

Tumor vascular emboli

Yes

293 (79.6%)

No

75 (20.4%)

Lymph node metastasis

Yes

153 (44%)

<0.0001

No

195 (56%)

Hormone receptor status (at least 1)

Yes

265 (73%)

0.030

No

98 (27%)


Visceral or lymph node (other than axillary) metastasis

Yes

136 (37%)

No

232 (63%)

Local recurrence

Yes

66 (18%)

No

302 (82%)

Oncological event (Metastasis and/or local recurrence)

Yes

157 (42.5%)

No

211 (57.5%)

Death

Yes

90 (24.46%)

No

278 (75.54%)


Oger et al. Diagnostic Pathology 2013 8(Suppl 1):S43   doi:10.1186/1746-1596-8-S1-S43

Open Data